price up icon7.80%   +0.89

Why is Vir Biotechnology Inc (VIR) Stock down?

We've noticed a 5.10% decline in Vir Biotechnology Inc (VIR) stock during the 2024-04-25 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
20 Jul, 2023:

Shares of Vir Biotechnology were down 44.90% on Thursday after the company announced phase 2 trial results for an influenza A therapy candidate. Vir announced that VIR-2482 failed to meet efficacy endpoints in a phase 2 trial for treating influenza A. The highest dose showed a non-statistically significant 16% reduction in illness. Disappointingly, VIR-2842 is the company's sole wholly owned candidate.


price down icon 0.65%
price up icon 0.63%
price up icon 0.65%
price up icon 2.13%
price up icon 2.51%
price down icon 0.11%
Cap:     |  Volume (24h):